Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;82:2235-2242

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colatsky, T. J.
Right arrow Articles by Starmer, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colatsky, T. J.
Right arrow Articles by Starmer, C. F.

Circulation, Vol 82, 2235-2242, Copyright © 1990 by American Heart Association


ARTICLES

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

TJ Colatsky, CH Follmer and CF Starmer
Division of Experimental Therapeutics, Wyeth-Ayerst Research, Princeton, New Jersey 08543.

Although work on class III antiarrhythmics remains at an early stage, these agents still appear to possess greater efficacy and less proarrhythmia than conventional class I agents in those experimental arrhythmia models considered to be most representative of the clinical situation. Although prolongation of repolarization carries with its own tendency for pause-dependent arrhythmogenesis (i.e., torsade de pointes), available data suggest that this may be a function of nonspecificity in potassium channel block rather than a general characteristic of class III activity. The availability of new and more selective blockers of specific cardiac potassium channels under development as class III agents have already helped to clarify basic questions about the ionic mechanism of repolarization in the heart, and one hopes that a growing clinical data base will eventually determine the relative safety and efficacy of these agents in preventing symptomatic and life-threatening arrhythmias.


This article has been cited by other articles:


Home page
Circ. Res.Home page
S. M. Schumacher, D. P. McEwen, L. Zhang, K. L. Arendt, K. M. Van Genderen, and J. R. Martens
Antiarrhythmic Drug-Induced Internalization of the Atrial-Specific K+ Channel Kv1.5
Circ. Res., June 19, 2009; 104(12): 1390 - 1398.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. H. Choi, J.-A. Park, K.-R. Kim, G.-I. Lee, Y.-T. Lee, H. Choe, S.-H. Ko, M.-H. Kim, Y.-H. Seo, and Y.-G. Kwak
Direct block of cloned hKv1.5 channel by cytochalasins, actin-disrupting agents
Am J Physiol Cell Physiol, August 1, 2005; 289(2): C425 - C436.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Choe, Y.-K. Lee, Y.-T. Lee, H. Choe, S.-H. Ko, C.-U. Joo, M.-H. Kim, G.-S. Kim, J.-S. Eun, J.-H. Kim, et al.
Papaverine Blocks hKv1.5 Channel Current and Human Atrial Ultrarapid Delayed Rectifier K+ Currents
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 706 - 712.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. D Pitt, C. Fernandes, N. L Bewick, P. D Hemsworth, K. A Buhagiar, P. S Hansen, H. H Rasmussen, L. Delbridge, and D. W Whalley
Chronic amiodarone-induced inhibition of the Na+-K+ pump in rabbit cardiac myocytes is thyroid-dependent: comparison with dronedarone
Cardiovasc Res, January 1, 2003; 57(1): 101 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. A Li, J. Miake, U. C Hoppe, D. C Johns, E. Marban, and H B. Nuss
Functional consequences of the arrhythmogenic G306R KvLQT1 K+ channel mutant probed by viral gene transfer in cardiomyocytes
J. Physiol., May 15, 2001; 533(1): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. N. Singh and J. S. M. Sarma
Mechanisms of Action of Antiarrhythmic Drugs Relative to the Origin and Perpetuation of Cardiac Arrhythmias
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 69 - 87.
[PDF]


Home page
Cardiovasc ResHome page
C. A Karle, V. A.W Kreye, D. Thomas, K. Rockl, S. Kathofer, W. Zhang, and J. Kiehn
Antiarrhythmic drug carvedilol inhibits HERG potassium channels
Cardiovasc Res, February 1, 2001; 49(2): 361 - 370.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. S. Kass and C. Cabo
Channel structure and drug-induced cardiac arrhythmias
PNAS, October 24, 2000; 97(22): 11683 - 11684.
[Full Text] [PDF]


Home page
J. Physiol.Home page
M. Weerapura, S. Nattel, M. Courtemanche, D. Doern, N. Ethier, and T. E Hebert
State-dependent barium block of wild-type and inactivation-deficient HERG channels in Xenopus oocytes
J. Physiol., July 15, 2000; 526(2): 265 - 278.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. K. Doshi and B. N. Singh
Reviews: Pure Class III Antiarrhythmic Drugs: Focus on Dofetilide
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 237 - 247.
[PDF]


Home page
Ann. Thorac. Surg.Home page
C. W. Hogue Jr and M. L. Hyder
Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment
Ann. Thorac. Surg., January 1, 2000; 69(1): 300 - 306.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Dorian and D. Newman
Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview
Europace, January 1, 2000; 2(4): 277 - 285.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. F. Bosch, G.-R. Li, R. Gaspo, and S. Nattel
Electrophysiologic Effects of Chronic Amiodarone Therapy and Hypothyroidism, Alone and in Combination, on Guinea Pig Ventricular Myocytes
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 156 - 165.
[Abstract] [Full Text]


Home page
EuropaceHome page
M.-H. Wu, M.-J. Su, and S.S.M. Sun
Electrophysiological profile after inward rectifier K channel blockade by barium in isolated rabbit hearts. Altered repolarization and unmasked decremental conduction property
Europace, January 1, 1999; 1(2): 85 - 95.
[Abstract] [PDF]


Home page
Circ. Res.Home page
N. I. Nenov, W. J. Crumb Jr, J. D. Pigott, L. H. Harrison Jr, and C. W. Clarkson
Quinidine Interactions With Human Atrial Potassium Channels : Developmental Aspects
Circ. Res., December 14, 1998; 83(12): 1224 - 1231.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W.-C. Yu, S.-A. Chen, S.-H. Lee, C.-T. Tai, A.-N. Feng, B. I.-T. Kuo, Y.-A. Ding, and M.-S. Chang
Tachycardia-Induced Change of Atrial Refractory Period in Humans : Rate Dependency and Effects of Antiarrhythmic Drugs
Circulation, June 16, 1998; 97(23): 2331 - 2337.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M A Vos, S R Golitsyn, K Stangl, M Y Ruda, L Van Wijk, J D Harry, K T Perry, P Touboul, G Steinbeck, and H J J Wellens
Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation
Heart, June 1, 1998; 79(6): 568 - 575.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Sen, G. Cui, Y. Sakaguchi, and B. N. Singh
Electrophysiological Effects of MS-551, a New Class III Agent: Comparison with dl-Sotalol in Dogs
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 687 - 694.
[Abstract] [Full Text]


Home page
NEJMHome page
A. A. Grace and A. J. Camm
Quinidine
N. Engl. J. Med., January 1, 1998; 338(1): 35 - 45.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Fiset, B. Drolet, B. A. Hamelin, and J. Turgeon
Block of IKs by the Diuretic Agent Indapamide Modulates Cardiac Electrophysiological Effects of the Class III Antiarrhythmic Drug dl-Sotalol
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 148 - 156.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
I. Kodama, K. Kamiya, and J. Toyama
Cellular electropharmacology of amiodarone
Cardiovasc Res, July 1, 1997; 35(1): 13 - 29.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W.-P. Yang, P. C. Levesque, W. A. Little, M. L. Conder, F. Y. Shalaby, and M. A. Blanar
KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias
PNAS, April 15, 1997; 94(8): 4017 - 4021.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Feng, Z. Wang, G.-R. Li, and S. Nattel
Effects of Class III Antiarrhythmic Drugs on Transient Outward and Ultra-rapid Delayed Rectifier Currents in Human Atrial Myocytes
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 384 - 392.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. N. Singh
Searching for the Ideal Class III Antiarrhythmic Agent: How Pure Should They Be?
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 239 - 242.
[PDF]


Home page
CirculationHome page
D. M. Roden, R. Lazzara, M. Rosen, P. J. Schwartz, J. Towbin, and G. M. Vincent
Multiple Mechanisms in the Long-QT Syndrome: Current Knowledge, Gaps, and Future Directions
Circulation, October 15, 1996; 94(8): 1996 - 2012.
[Abstract] [Full Text]


Home page
CirculationHome page
C. Valenzuela, E. Delpon, L. Franqueza, P. Gay, O. Perez, J. Tamargo, and D. J. Snyders
Class III Antiarrhythmic Effects of Zatebradine: Time-, State-, Use-, and Voltage-Dependent Block of hKv1.5 Channels
Circulation, August 1, 1996; 94(3): 562 - 570.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
L. Wang, Z.-P. Feng, C. S. Kondo, R. S. Sheldon, and H. J. Duff
Developmental Changes in the Delayed Rectifier K+ Channels in Mouse Heart
Circ. Res., July 1, 1996; 79(1): 79 - 85.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
S. G. Priori, C. Napolitano, F. Cantu, A. M. Brown, and P. J. Schwartz
Differential Response to Na+ Channel Blockade, ß-Adrenergic Stimulation, and Rapid Pacing in a Cellular Model Mimicking the SCN5A and HERG Defects Present in the Long-QT Syndrome
Circ. Res., June 1, 1996; 78(6): 1009 - 1015.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
G.-R. Li, J. Feng, L. Yue, M. Carrier, and S. Nattel
Evidence for Two Components of Delayed Rectifier K+ Current in Human Ventricular Myocytes
Circ. Res., April 1, 1996; 78(4): 689 - 696.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Focaccio, G. Peeters, M. Movsesian, R. Roden, Y. Eki, J. Krall, and M. R. Bristow
Mechanism of Action of OPC-8490 in Human Ventricular Myocardium
Circulation, February 15, 1996; 93(4): 817 - 825.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
G. A. Gintant
Two Components of Delayed Rectifier Current in Canine Atrium and Ventricle : Does IKs Play a Role in the Reverse Rate Dependence of ClassIII Agents?
Circ. Res., January 1, 1996; 78(1): 26 - 37.
[Abstract] [Full Text]


Home page
CirculationHome page
M. W. Veldkamp, A. C.G. van Ginneken, T. Opthof, and L. N. Bouman
Delayed Rectifier Channels in Human Ventricular Myocytes
Circulation, December 15, 1995; 92(12): 3497 - 3504.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. J. Duff, Z.-P. Feng, and R. S. Sheldon
High- and Low-Affinity Sites for [3H]Dofetilide Binding to Guinea Pig Myocytes
Circ. Res., October 1, 1995; 77(4): 718 - 725.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Mori, Y. Hara, T. Saito, Y. Masuda, and H. Nakaya
Anticholinergic Effects of Class III Antiarrhythmic Drugs in Guinea Pig Atrial Cells : Different Molecular Mechanisms
Circulation, June 1, 1995; 91(11): 2834 - 2843.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Yang, D. J. Snyders, and D. M. Roden
Ibutilide, a Methanesulfonanilide Antiarrhythmic, Is a Potent Blocker of the Rapidly Activating Delayed Rectifier K+ Current (IKr) in AT-1 Cells : Concentration-, Time-, Voltage-, and Use-Dependent Effects
Circulation, March 15, 1995; 91(6): 1799 - 1806.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
E. Delpon, C. Valenzuela, O. Perez, O. Casis, and J. Tamargo
Propafenone Preferentially Blocks the Rapidly Activating Component of Delayed Rectifier K+ Current in Guinea Pig Ventricular Myocytes : Voltage-Independent and Time-Dependent Block of the Slowly Activating Component
Circ. Res., February 1, 1995; 76(2): 223 - 235.
[Abstract] [Full Text]